Italia markets open in 2 hours 48 minutes
Dow Jones
37.903,29 +87,37 (+0,23%) Nasdaq
15.605,48 -52,34 (-0,33%) Nikkei 225
38.269,50 -4,55 (-0,01%) EUR/USD
1,0719 +0,0001 (+0,01%) Bitcoin EUR
53.592,74 -2.557,36 (-4,55%) CMC Crypto 200
1.261,62 -77,44 (-5,78%)
UCB SA (0NZT.IL)
IOB - IOB Prezzo differito. Valuta in EUR.
Aggiungi a watchlist
Alla chiusura: 05:36PM BST
| Chiusura precedente | 124,80 |
| Aperto | 0,00 |
| Denaro | 0,00 x 0 |
| Lettera | 0,00 x 0 |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 245.936 |
| Capitalizzazione | 25,393B |
| Beta (5 anni mensile) | 0,34 |
| Rapporto PE (ttm) | 73,41 |
| EPS (ttm) | 1,70 |
| Prossima data utili | 24 lug 2024 - 03 ago 2024 |
| Rendimento e dividendo (futuro) | 1,33 (1,84%) |
| Data ex dividendo | 28 apr 2023 |
| Stima target 1A | N/D |
GlobeNewswireClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery
SOLANA BEACH, Calif., May 24, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has entered into a multi-year license agreement with UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical leader, to partner on drug delivery platforms for UCB’s gene therapy portfolio. “We are extremely excited to partner with UCB, a global biopharmaceutical leader, with a focus on inno
© 2024 Yahoo. Tutti i diritti riservati.